Compare AM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AM | RGEN |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | United States |
| Employees | N/A | 2000 |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 6.6B |
| IPO Year | 2017 | 1995 |
| Metric | AM | RGEN |
|---|---|---|
| Price | $22.79 | $115.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 11 |
| Target Price | $22.50 | ★ $172.91 |
| AVG Volume (30 Days) | ★ 2.3M | 873.1K |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.98% | N/A |
| EPS Growth | 3.61 | ★ 286.96 |
| EPS | 0.86 | 0.86 |
| Revenue | ★ $1,188,426,000.00 | $141,236,000.00 |
| Revenue This Year | $4.92 | $14.30 |
| Revenue Next Year | $6.74 | $14.52 |
| P/E Ratio | ★ $26.27 | $136.09 |
| Revenue Growth | 7.43 | ★ 35.10 |
| 52 Week Low | $15.08 | $105.06 |
| 52 Week High | $23.84 | $175.77 |
| Indicator | AM | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.98 | 41.20 |
| Support Level | $22.45 | $112.05 |
| Resistance Level | $23.84 | $130.56 |
| Average True Range (ATR) | 0.54 | 4.53 |
| MACD | -0.16 | 1.25 |
| Stochastic Oscillator | 36.45 | 47.57 |
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.